Sponsor or institution
Clinical trials and research at Neonc Technologies, Inc.
As of November 12, 2026, Find a Trial lists 3 clinical trials run by Neonc Technologies, Inc. that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1), Phase 1/2 (1). There are also 1 NIH-funded research project at this institution, with $1.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1NIH research projects
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Intranasal NEO100 for Pediatric Brain Tumors: Safety and Dosing | Phase 1 | Orange, California | Recruiting | Apr 10, 2024 |
| Testing NEO212 for treating certain brain tumors and metastases | Phase 1/2 | Beverly Hills, California and 7 other locations | Recruiting | Sep 21, 2023 |
| Treatment of high-grade meningioma with NEO100 | Phase 2 | Los Angeles, California and 4 other locations | Recruiting | Aug 26, 2021 |
All recruiting trials (3)
-
Intranasal NEO100 for Pediatric Brain Tumors: Safety and Dosing
We’re testing whether delivering NEO100 through the nose is safe and achievable at higher doses for children with certain brain tumors.
-
Testing NEO212 for treating certain brain tumors and metastases
This study is testing a new treatment called NEO212 for people with certain types of brain tumors to see if it is safe and effective when combined with standard treatments.
-
Treatment of high-grade meningioma with NEO100
This study is testing a new treatment called NEO100 to see if it can help patients with high-grade meningioma that hasn't completely gone away after surgery.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Making radiation more effective for temozolomide‑resistant glioblastoma
This project adds a new drug called NEO212 to radiation to help adults whose glioblastoma no longer responds to temozolomide.
Quick answers
How many clinical trials run by Neonc Technologies, Inc. are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.